VOGT FREDERICK G (Interim CEO & General Counsel) exercised options at IOVANCE BIOTHERAPEUTICS, INC.
Option exercise — a mechanical event triggered by vesting or expiry. Not a discretionary conviction trade.
M · 1 exercise
Filed: 3/6/2026ACC: 0001104659-26-024765
DirectorOfficer· Interim CEO & General Counsel
Since Mar 2026
-26.75K
Net shares
Net seller
$122.5K
Total sold
0
Open market trades
0B · 0S
3
Total transactions
62.49K acquired · 89.25K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+62.49K
Price / share
—
Trade value
—
% of position
12.7%
3/5/2026
493.80K→556.29K
Common Stock
Direct
Shares
−26.75K
Price / share
$4.58
Trade value
$122.54K
% of position
4.8%
3/5/2026
556.29K→529.54K
Total
Net shares
+35.74K
Net value
-$122.54K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/5/2026 | M · Option Exercise | +62.49K | — | — | 12.7% | 493.80K | 556.29K |
| Common Stock Direct | 3/5/2026 | F · Tax Withholding | −26.75K | $4.58 | $122.54K | 4.8% | 556.29K | 529.54K |
| Total | +35.74K | -$122.54K | ||||||
Derivative Transactions1
Restricted Stock Units
Direct
Converts to
Common stock
62.49K shares
Shares
−62.49K
Strike price
Held after
125.01K
Exercisable
—
3/5/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common stock62.49K shares | 3/5/2026 | M · Option Exercise | −62.49K | — | 125.01K |